Vectors TRIZ Cases
- Sortase-Mediated AAV Capsid Conjugation for Targeting
Sortase recognition sequences enable covalent targeting molecule conjugation to AAV capsids while maintaining production yield.
- Trans-pseudotyping Recombinant AAV Production
Trans-pseudotyping produces recombinant AAV particles by infecting host cells with first-stage viral vectors to deliver genomes for second-stage encapsidation.
- Somatic Cell Reprogramming for Autologous Pluripotency
Viral transduction of somatic cells generates autologous pluripotent stem cells, eliminating immune rejection risks associated with embryonic sources.
- Arabinose-Inducible Expression Vector with T7 Epsilon Enhancer
Hybrid vectors merge arabinose regulation with translational enhancement elements, resolving the trade-off between tight control and high productivity.
- AUF1 Protein AAV Vectors Muscle Regeneration
AAV vectors delivering AUF1 stabilize the sarcolemma and promote slow-twitch fiber formation to reverse atrophy.
- Nanocapsule Drug Delivery for Blood-Brain Barrier Penetration
Self-assembling capsid proteins form nanocapsules that ferry orexin mRNA across the blood-brain barrier to treat neurodegenerative diseases.
- Non-viral Transgenesis via Integrase-Mediated Cassette Integration
Engineered transgene cassettes integrate efficiently into the host genome via retroviral integrase, bypassing viral immunogenicity and size constraints.
- Replication-Defective HSV-2 Vaccine with Dominant-Negative Mutants
A replication-defective HSV-2 vaccine uses dominant-negative mutants to elicit broad immune responses.
- Cardiac Stress-Induced Promoter Mitochondrial Targeting for Right Ventricular Dysfunction
A nucleic acid construct links a cardiac stress promoter to a mitochondrial targeting sequence for precise gene delivery.
- SspH1 LRR-NEL System for Inducible Protein Degradation in Plant Cells
A SspH1-based protein degradation system utilizing NEL and HR1b domains to target specific proteins in plant cells.
- AAVhu68 Vector for Fabry Disease Enzyme Delivery
AAVhu68 capsids protect hGLA sequences and enable targeted uptake, solving stability and variable delivery issues in Fabry disease treatment.
- Constitutive Promoters for Low Metabolic Burden Bacterial Expression
Synthetic regulatory nucleic acid molecules confer reduced constitutive expression, eliminating inducer dependency and resolving plasmid yield limitations.
- Modified Mesenchymal Cells Expressing Decorin for Fibrosis Treatment
Engineered mesenchymal cells express the decoy receptor Decorin to bind TGF-β and inhibit fibrotic tissue progression.
- Sorghum Cytochrome P450 Enzymes Sorgoleone Biosynthesis
Novel sorghum cytochrome P450 enzymes convert pentadecatrienyl resorcinol to dihydrosorgoleone.
- RGMc Knockout Mouse Model for Iron Metabolism Study
A transgenic RGMc knockout mouse model enables detection of iron accumulation mechanisms through targeted gene disruption in embryonic stem cells.
- Genetic Construct with MicroRNA Detector for T-ALL Targeting
A recombinant genetic construct uses microRNA target sites to regulate therapeutic gene expression in cancer cells.
- AAV Rep78 Sequence Deoptimization for Hybrid Virus Stability
Deoptimized AAV Rep78 sequences resolve adenoviral inhibition, enabling stable hybrid virus production.
- AAV1-Caspase Gene Therapy for Schwannoma Treatment
An AAV1 vector delivers caspase-1 to induce pyroptosis in schwannoma cells.
- Hypoimmune Pluripotent Cells for Universal Cell Therapy
Genetically modified pluripotent stem cells evade immune rejection through targeted gene knockout and CD47 overexpression.
- Expression Vector With IRES And Glutamine Synthetase Selection
An expression vector uses an internal ribosome entry site to drive glutamine synthetase for cell selection.
- SynP160 Promoter Expression Cassette for Rod Photoreceptor Targeting
A nucleic acid sequence drives gene expression in rod photoreceptors using a specific promoter.
- KoRV Envelope Glycoproteins for NK Cell Transduction
KoRV envelope glycoproteins pseudotype lentiviral vectors to transduce natural killer cells without pre-activation.
- Hypercascade Arrays for Lineage Reconstruction
Segmented hypercascade arrays enable deep lineage reconstruction over long time scales while maintaining spatial context.
- Engineered UTRs for AAV Protein Expression Control
Engineered untranslated regions control AAV capsid and replication protein expression ratios.
- Circular RNA Urate Oxidase Expression Low Immunogenicity
Circular RNA constructs express urate oxidase via intron-mediated splicing, reducing immunogenicity compared to foreign protein sources.
- Hybrid Promoter Combining mCMV Enhancer and EF-1alpha Intron
A hybrid promoter merges a murine CMV enhancer with a rat EF-1alpha intron to drive recombinant protein expression in mammalian host cells.
- Hepatitis B Cis-Regulatory Element for Protein Expression
Hepatitis B virus-derived cis-regulatory elements boost protein expression levels across diverse cell types without altering transcriptional rates.
- Self-limiting rAAV Vectors for Controlled Genome Editing
Self-limiting rAAV vectors incorporate endonuclease recognition sequences, limiting vector persistence and preventing immune responses.
- hHLA Promoter Sequence for Microglia-Specific Transgene Expression
The hHLA promoter resolves insufficient transgene expression in immune cells by incorporating NF-kappaB and AP-1 binding sites.
- Oncolytic Adenovirus Armed with Chimeric CD40 Ligand
Engineering replication-competent adenoviruses with chimeric CD40 ligands resolves the trade-off between viral tumor lysis and systemic immune activation.
- Programmable Differentiation Control Network for Stem Cell Fate
A transgenic differentiation-control network uses ligand-responsive receptors to activate transcription factors.
- EF1g Gene Attenuation via DDD Regulatory System
Conditional EF1g regulation via a DDD element resolves safety and controllability contradictions in malaria vaccine production.
- Optimizing circRNA Expression Frame Lengths for Circularization
A 173 bp circRNA expression vector uses optimized flanking sequences to enable efficient circularization.
- Compact AAV Vectors for Gene Therapy Using JeT Promoter and Synthetic Intron
A recombinant vector uses a JeT promoter and synthetic intron to express transgenes within adeno-associated virus packaging limits.
- Nucleic Acid Construct for Stable Cell Line Generation
Optimized nucleic acid construct integrates into amniocytic cells to establish permanent, genetically stable lines.
- Light-Switchable Gene Expression via Recombinant Transcription Factor
A recombinant transcription factor uses light to control gene expression with high spatiotemporal precision.
- Transgenic Mammals Secreting Proteins in Milk
Mammary gland tissue-specific promoters direct transgenic protein secretion into milk, simplifying purification from toxic blood products.
- Bidirectional hCMV-CAG4 Promoter for Balanced Transgene Expression
A bidirectional hCMV-CAG4 promoter coordinates two transgenes using a head-to-head configuration with a central enhancer.
- Segmented Chromatin Insulator in Lentiviral Vectors
Segmented cHS4 insulators maintain transgene stability while preserving high viral titers, resolving the trade-off between safety and productivity.
- AAV9 Gene Therapy for Galactosemia
Recombinant AAV9 vectors deliver GALT genes to restore metabolic function, addressing galactose-1-phosphate accumulation and disease progression.
- AAV Vector Mitochondrial Gene Delivery
Mitochondrial targeting sequences on AAV vectors enable direct mtDNA correction, resolving the bottleneck of intracellular organelle transfection.
- Protease-Activatable AAV Capsid Peptide Locks for Targeted Gene Delivery
Protease-cleavable peptide locks on AAV capsids restrict transduction to diseased tissues, resolving specificity trade-offs.
- Recombinant Expression System for Robust Cellular Network Control
A recombinant expression system uses controller molecules to regulate actuator activity within cellular networks.
- Expression Vector Enhances Protein Yield via Regulatory Elements
Novel expression vector combines CMV promoter and tripartite leader to boost recombinant protein production in mammalian cells.
- mRNA UGT1A1 Therapy for Crigler-Najjar Syndrome Bilirubin Reduction
Lipid nanoparticle delivery of modified mRNA restores UGT1A1 activity, reducing bilirubin accumulation and avoiding invasive liver transplant risks.
- Tunable Phosphorylation Feedback Controller for Mammalian Gene Expression
A tunable phosphorylation feedback controller regulates mammalian gene expression using bacterial two-component signaling systems.
- Wild-Type Tau Nerve Cell Model for Alzheimer's Drug Screening
Inducible wild-type tau overexpression reproduces neurodegenerative pathophysiology without toxic agents, enabling efficient drug candidate screening.
- Stem Cell Differentiation via Transcription Factor Engineering
Pre-programming stem cells with HNF and FOX family genes accelerates hepatocyte generation within 30 days, bypassing complex multi-step media protocols.